Alexander Levitzki Selected Research

Alexander Levitzki Research Topics

Disease

54	Neoplasms (Cancer) 11/2019 - 02/2002
6	Breast Neoplasms (Breast Cancer) 01/2016 - 08/2003
4	Prostatic Neoplasms (Prostate Cancer) 04/2017 - 04/2007
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2010 - 09/2002
3	Melanoma (Melanoma, Malignant) 01/2018 - 01/2012
3	Glioblastoma (Glioblastoma Multiforme) 10/2011 - 11/2005
3	Inflammation (Inflammations) 06/2005 - 06/2004
2	Septic Shock (Toxic Shock Syndrome) 01/2018 - 06/2004
2	Multiple Myeloma 02/2014 - 12/2011
2	Leukemia 12/2011 - 09/2002
2	Carcinoma (Carcinomatosis) 05/2011 - 04/2009
2	Glioma (Gliomas) 04/2011 - 09/2002
2	Starvation 10/2010 - 07/2007
2	Carcinogenesis 06/2010 - 02/2002
2	Hematologic Neoplasms (Hematological Malignancy) 05/2007 - 09/2002
2	Sarcoma (Soft Tissue Sarcoma) 01/2007 - 01/2004
2	Neointima 02/2005 - 10/2004
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2004 - 06/2003
2	Lung Neoplasms (Lung Cancer) 08/2003 - 06/2003
1	Shock 01/2018
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 12/2017
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2014
1	Genomic Instability 08/2013
1	Brain Neoplasms (Brain Tumor) 10/2011
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2007
1	Papilloma (Papillomatosis) 05/2007
1	Colorectal Neoplasms (Colorectal Cancer) 05/2007
1	Neoplasm Metastasis (Metastasis) 04/2007

Drug/Important Bio-Agent (IBA)

9	Tyrosine Kinase InhibitorsIBA 11/2019 - 09/2002
9	TyrphostinsIBA 12/2014 - 09/2002
8	ErbB Receptors (EGF Receptor)IBA 04/2014 - 05/2004
7	CytokinesIBA 01/2018 - 09/2002
7	Phosphotransferases (Kinase)IBA 05/2007 - 02/2002
6	Proteins (Proteins, Gene)FDA Link 04/2017 - 05/2005
6	Imatinib Mesylate (Gleevec)FDA Link 01/2013 - 09/2002
5	RNA (Ribonucleic Acid)IBA 10/2011 - 09/2002
5	Double-Stranded RNA (RNA, Double Stranded)IBA 10/2011 - 09/2002
4	Tyrosine (L-Tyrosine)FDA Link 11/2019 - 09/2002
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2019 - 09/2002
3	Pharmaceutical PreparationsIBA 01/2018 - 10/2002
3	AntibodiesIBA 01/2016 - 08/2003
3	LigandsIBA 01/2016 - 03/2011
3	CytosineIBA 01/2012 - 01/2006
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 07/2011 - 08/2002
3	Cisplatin (Platino)FDA LinkGeneric 04/2009 - 12/2002
3	src-Family KinasesIBA 01/2007 - 02/2003
3	Radioisotopes (Radionuclides)IBA 01/2007 - 07/2004
3	Antisense RNA (Anti-Sense RNA)IBA 11/2005 - 08/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2005 - 06/2003
3	AG 556IBA 06/2005 - 06/2003
2	AntigensIBA 12/2017 - 04/2017
2	AndrogensIBA 04/2017 - 12/2014
2	Poly I-CIBA 04/2017 - 04/2011
2	Trastuzumab (Herceptin)FDA Link 01/2016 - 08/2003
2	Insulin ReceptorIBA 12/2014 - 07/2013
2	Nucleic AcidsIBA 09/2014 - 10/2011
2	Epidermal Growth Factor (EGF)IBA 04/2012 - 04/2011
2	PolyethyleneimineIBA 04/2012 - 04/2011
2	eIF-2 Kinase (eIF 2 Kinase)IBA 01/2012 - 09/2002
2	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 12/2011 - 09/2002
2	Benzo(a)pyreneIBA 05/2011 - 06/2010
2	Messenger RNA (mRNA)IBA 06/2010 - 08/2004
2	Adenosine Triphosphate (ATP)IBA 05/2007 - 01/2006
2	AgarIBA 05/2007 - 10/2003
2	AG-879IBA 01/2007 - 01/2004
2	tyrphostin AGL-2043IBA 02/2005 - 10/2004
2	Biomarkers (Surrogate Marker)IBA 05/2004 - 10/2002
2	Gefitinib (Iressa)FDA Link 08/2003 - 06/2003
1	Bacterial ToxinsIBA 01/2018
1	SuperantigensIBA 01/2018
1	Tuberculin (PPD)IBA 12/2017
1	Recombinant Fusion ProteinsIBA 01/2016
1	Docetaxel (Taxotere)FDA Link 12/2014
1	Insulin-Like PeptidesIBA 12/2014
1	degrasynIBA 02/2014
1	Monoclonal AntibodiesIBA 08/2013
1	VaccinesIBA 08/2013
1	VemurafenibIBA 07/2013
1	Toll-Like Receptor 3IBA 01/2012
1	Carrier Proteins (Binding Protein)IBA 01/2012
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2012
1	UbiquitinIBA 12/2011
1	Protein Kinases (Protein Kinase)IBA 04/2011
1	AMP-Activated Protein KinasesIBA 04/2011
1	Adenosine Monophosphate (AMP)IBA 04/2011
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 04/2011
1	ChemokinesIBA 03/2011
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2010
1	Amino Acids FDA Link 10/2010
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 05/2007
1	Prostate-Specific Antigen (Semenogelase)IBA 04/2007
1	GL-2003IBA 01/2007
1	Estrogens (Estrogen)FDA Link 01/2007

Therapy/Procedure

25	Therapeutics 11/2019 - 05/2002
3	Drug Therapy (Chemotherapy) 04/2009 - 10/2002
2	Immunotherapy 11/2019 - 08/2013
2	Stents 02/2005 - 10/2004
1	Intravenous Administration 04/2011
1	Intraperitoneal Injections 03/2011